Trial Profile
Subject And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, Parallel Group Study to Assess Effects of PF-04958242 on Bold Functional MRI During Working Memory Activation and Arterial Spin Labeling at Rest in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Dec 2019
Price :
$35
*
At a glance
- Drugs Pesampator (Primary)
- Indications Cognition disorders
- Focus Pharmacodynamics
- Sponsors Pfizer
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2012 Planned End Date changed from 1 Oct 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov record.
- 26 Sep 2012 Planned End Date changed from 1 Jan 2013 to 1 Oct 2012 as reported by ClinicalTrials.gov record.